SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is attracting significant community attention and discussion, particularly as its proponents rally around the upcoming 4/20 event, promoting its mission to advance global cannabis culture and legalization on the Solana blockchain as a crypto 'like Bitcoin but way higher'.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to its highly active community's relentless focus on building a "permissionless brand," highlighted by the continuous launch of real-world products like "Kendu Spice" and "Kendu Unleashed" skateboards. The community remains overwhelmingly bullish, emphasizing the project's strong fundamentals and long-term vision amidst prevailing market conditions.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares (LABU) is experiencing a strong rally, propelled by increasing market conviction in AI's transformative role in drug discovery, significant M&A activity, and growing expectations for rate cuts that are driving a sector-wide breakout.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending amidst community frustration and significant losses as the biotech sector (XBI) maintains an unexpected bull run, driven by ongoing M&A and perceived market manipulation, defying numerous bearish technical indicators.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST is capturing attention as the "privacy layer of Solana," bolstered by integrations with Solflare and partnerships like Zebec, with its low market cap sparking community excitement for substantial growth and utility in the current market.

WorldFinancial

WLFI is trending as it faces a U.S. House investigation into a significant $500 million investment deal, sparking a polarized community debate. While many critics denounce it as a politically-linked "scam," proponents are aggressively buying dips, anticipating future growth from its planned app and real-world asset tokenization initiatives.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF (UVXY) is trending due to ongoing geopolitical tensions and market uncertainty, with investors actively debating its potential for significant volatility spikes as a hedge against downturns, while others focus on shorting rallies given its inherent decay.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending as its collaboration with OpenAI on an AI-driven autonomous lab, achieving significant cost reductions in protein synthesis, sparks community debate on its potential as critical national biotechnology infrastructure amid broader sector tailwinds for AI and biodefense.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is trending as investors seek a flight to safety, with the dividend-focused ETF holding strong and showing green performance during broader market downturns. The community is actively discussing a potential rotation from high-growth tech into value and income strategies, reinforcing SCHD's appeal as a long-term, defensive holding.

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Mckesson Corporation

McKesson (MCK) is trending after reporting strong earnings that beat estimates and raising its fiscal year guidance, igniting bullish sentiment across the community. Investors are highlighting its consistent performance as a healthcare sector "juggernaut," driven by robust growth in specialty distribution and oncology, leading to multiple analyst price target upgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Elevance Health, Inc. $ELV Shares Sold by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lessened its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 9.4% in the 3rd quarter, according to its most recent 13F filing with the Securities...

Ironwood Investment Counsel LLC Takes $2.55 Million Position in Elevance Health, Inc. $ELV

Ironwood Investment Counsel LLC purchased a new position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) in the third quarter, according to the company in its most recent filing with the...

TenCore Partners LP Invests $11.31 Million in Elevance Health, Inc. $ELV

TenCore Partners LP acquired a new stake in Elevance Health, Inc. (NYSE:ELV - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The...

Will Declining Medical Membership Affect Humana's Q4 Earnings?

HUM heads into Q4 with declining medical membership and rising costs, clouding earnings despite expectations for solid revenue growth.

Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength 

CNC incurs a Q4 adjusted loss per share as medical costs spike, but revenues jump nearly 22% on strong PDP and Marketplace premium growth.

Ensign Group Q4 Earnings Beat Estimates on Growing Occupancy

ENSG tops Q4 EPS estimates as occupancy rose sharply, lifting earnings nearly 20% year over year despite higher costs and a slight revenue miss.

Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge

Molina Healthcare posts Q4 loss as medical costs surge, even as revenues rise 8% and full-year sales top expectations.

Elevance Health, Inc. $ELV Shares Purchased by Bessemer Group Inc.

Bessemer Group Inc. increased its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 5.9% in the 3rd quarter, according to the company in its most recent disclosure with the...

C WorldWide Group Holding A S Has $28.44 Million Holdings in Elevance Health, Inc. $ELV

C WorldWide Group Holding A S trimmed its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 3.4% during the 3rd quarter, according to its most recent Form 13F filing with the...

Elevance Health, Inc. $ELV Holdings Raised by High Ground Investment Management LLP

High Ground Investment Management LLP grew its stake in Elevance Health, Inc. (NYSE:ELV - Free Report) by 19.1% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned...

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$10.57	--	--	N/A
Q4 '25	$3.10	$3.33	7.54%	BEAT
Q3 '25	$4.93	$6.03	22.24%	BEAT
Q2 '25	$8.91	$8.84	-0.78%	MISSED
Q1 '25	$11.41	$11.97	4.89%	BEAT

ELV
Elevance Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest ELV News

ELVElevance Health Inc